SecBot SecBot
SECBOTREPLAY Home › Report › ANAB

ANAB · Two corporate insiders at AnaptysBio sold shares worth $731K within a…

ANAPTYSBIO, INC · CLUSTER filed Mar 26, 2026 at 20:00 ET

At the news

BEARISHIMPACT 7/10

CLUSTER filed Mar 26, 2026 at 20:00 ET

Two corporate insiders at AnaptysBio sold shares worth $731K within a 7-day window, including CEO Daniel Faga and Director John Schmid, shortly after the company announced a securities purchase agreement related to a spin-off of its subsidiary First Tracks Biotherapeutics. The timing suggests potential awareness of material non-public developments.

  • CEO Daniel Faga and Director John Schmid sold a combined $731K in shares over 7 days
  • Sales occurred between March 27 and March 30, 2026, immediately following an 8-K filing disclosing a material agreement for a spin-off and private placement
  • Total insider selling represents approximately 0.046% of AnaptysBio's $1.6B market cap
  • The 8-K (filed March 27) disclosed a securities purchase agreement for First Tracks Biotherapeutics, a wholly-owned subsidiary, to be spun off to AnaptysBio shareholders

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access